Matthew Ros

Insider Reports History

Location
C/O Epizyme, Inc., 400 Technology Square, Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Ros:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verastem, Inc. Chief Operating Officer Common Stock 50K $352K $7.04 Apr 1, 2025 Direct
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44.7K $321K $7.19 Jun 4, 2025 Direct
Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer Common Stock, par value $0.0001 111K $157K $1.41 Aug 16, 2021 Direct
Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer Stock Option (Right to Buy) 134K $75.1K $0.56 Aug 16, 2021 Direct

Insider Reports Filed by Matthew Ros

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jun 4, 2025 1 $0 4 Jun 5, 2025 Director
VSTM Verastem, Inc. Apr 1, 2025 1 $0 4 Apr 3, 2025 Chief Operating Officer
VSTM Verastem, Inc. Jan 14, 2025 0 $0 3 Jan 21, 2025 Chief Operating Officer
COGT Cogent Biosciences, Inc. Jun 5, 2024 1 $0 4 Jun 13, 2024 Director
COGT Cogent Biosciences, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
COGT Cogent Biosciences, Inc. Oct 2, 2023 1 $0 4 Oct 3, 2023 Director
COGT Cogent Biosciences, Inc. Jul 3, 2023 1 $0 4 Jul 5, 2023 Director
COGT Cogent Biosciences, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
COGT Cogent Biosciences, Inc. Apr 3, 2023 1 $0 4 Apr 4, 2023 Director
COGT Cogent Biosciences, Inc. Jan 3, 2023 1 $12.9K 4 Jan 4, 2023 Director
COGT Cogent Biosciences, Inc. Oct 3, 2022 1 $12.9K 4 Oct 4, 2022 Director
COGT Cogent Biosciences, Inc. Jul 1, 2022 1 $12.9K 4 Jul 5, 2022 Director
COGT Cogent Biosciences, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
COGT Cogent Biosciences, Inc. Apr 1, 2022 1 $12.9K 4 Apr 5, 2022 Director
COGT Cogent Biosciences, Inc. Jan 3, 2022 1 $11.6K 4 Jan 4, 2022 Director
COGT Cogent Biosciences, Inc. Oct 1, 2021 1 $12.4K 4 Oct 5, 2021 Director
EPZM Epizyme, Inc. Aug 16, 2021 2 $0 4 Aug 18, 2021 Executive Vice President, Chief Strategy & Business Officer
COGT Cogent Biosciences, Inc. Jul 1, 2021 1 $10.6K 4 Jul 6, 2021 Director